Specialty Pharmacy

Study finds a pattern of disconnectivity among executive areas of the brain.

Class of receptors may be precisely targeted by drug compounds.

Study finds substantial minority living with undiagnosed HIV infection.

Autobiographical memory and episodic future thinking reduced in MS patients.

The latest news in oncology treatment research.

Both conditions are separate diseases with different causes, diagnostic procedures, and treatments.

Study finds public opinion surrounding medical marijuana may influence treatment decisions.

Some complementary or alternative medications can have an adverse reaction mixed with cancer drugs.

Advocates seek to eradicate the disease by 2030.

Biologic therapy targets genetic defects found in various cancers.

Top stories of the week on Specialty Pharmacy Times.

Baked potato extract found to suppress the spread of colon cancer stem cells.

Study suggests testing sites in high schools may increase the likelihood of getting an HIV test.

Study shows nitroglycerin may improve the delivery of anticancer drugs.

Health care providers urged to counsel lung transplant recipients on the risks connected with skin cancer, light protection, and routine screening.

Minor benefit found adult patients with grade II, or moderate, COPD when adding aclidinium bromide and formoterol.

Obesity leads to biomechanical changes that create the right conditions for tumor growth.

Varubi prevents nausea and vomiting associated with vomit-inducing cancer chemotherapy.

Dispensing medical marijuana may soon become an issue for specialty pharmacy.

Cancer therapy filgrastim-sndz (Zarxio) was initially approved on March 6, 2015.

Oncologists will now be able to measure progress in cancer treatments.

Addition of docetaxel had the greatest benefit in patients with a high burden of metastatic disease.

Pharmacists vital in helping HIV-infected women stay adherent to their treatment regimen.

Discovery holds promise for patients with Crohn's disease, diabetes, ulcerative colitis, and more.

RA drug found to improve physical and emotional well-being among patients.

Elotuzumab is an immunostimulatory antibody combination therapy for patients who received one or more prior therapies.

Genentech official sheds light on the current cancer drug pipeline.

HbA1C significantly decreased in adults with poorly controlled type 2 diabetes.

Findings could lead to effective new cancer treatments.

Findings may lead to safer cancer treatments without side effects harmful to the brain.